RS20060016A - Semi-solid systems containing azetidine derivatives - Google Patents
Semi-solid systems containing azetidine derivativesInfo
- Publication number
- RS20060016A RS20060016A YUP-2006/0016A YUP20060016A RS20060016A RS 20060016 A RS20060016 A RS 20060016A YU P20060016 A YUP20060016 A YU P20060016A RS 20060016 A RS20060016 A RS 20060016A
- Authority
- RS
- Serbia
- Prior art keywords
- semi
- systems containing
- azetidine derivatives
- solid systems
- containing azetidine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Polučvrsti sistemi koji sadrže derivate azetidina. Predstavljeni pronalazak se odnosi na nove formulacije derivata azetidina za oralnu primenu.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03291796A EP1498122A1 (en) | 2003-07-18 | 2003-07-18 | Semi-solid systems containing azetidine derivatives |
PCT/EP2004/008553 WO2005013973A1 (en) | 2003-07-18 | 2004-07-08 | Semi-solid systems containing azetidine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
RS20060016A true RS20060016A (en) | 2008-06-05 |
Family
ID=33462259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-2006/0016A RS20060016A (en) | 2003-07-18 | 2004-07-08 | Semi-solid systems containing azetidine derivatives |
Country Status (30)
Country | Link |
---|---|
US (2) | US20050026898A1 (sr) |
EP (2) | EP1498122A1 (sr) |
JP (1) | JP2009513560A (sr) |
KR (1) | KR20060040691A (sr) |
CN (1) | CN1822831A (sr) |
AR (1) | AR045997A1 (sr) |
AU (1) | AU2004262498B2 (sr) |
BR (1) | BRPI0412737A (sr) |
CA (1) | CA2532669A1 (sr) |
CR (1) | CR8179A (sr) |
EC (1) | ECSP066292A (sr) |
GT (1) | GT200400135A (sr) |
HR (1) | HRP20060022A2 (sr) |
IL (1) | IL173111A0 (sr) |
MA (1) | MA27922A1 (sr) |
MX (1) | MXPA06000483A (sr) |
MY (1) | MY142077A (sr) |
NO (1) | NO20060509L (sr) |
OA (1) | OA13191A (sr) |
PA (1) | PA8606701A1 (sr) |
PE (1) | PE20050287A1 (sr) |
RS (1) | RS20060016A (sr) |
RU (1) | RU2343915C2 (sr) |
SG (1) | SG144141A1 (sr) |
TN (1) | TNSN06013A1 (sr) |
TW (1) | TW200522945A (sr) |
UA (1) | UA80633C2 (sr) |
UY (1) | UY28421A1 (sr) |
WO (1) | WO2005013973A1 (sr) |
ZA (1) | ZA200600490B (sr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2007123366A (ru) * | 2004-11-24 | 2008-12-27 | Мерк Энд Ко. | Жидкие и полутвердые фармацевтические препаративные формы для перорального введения замещенного амида |
FR2923719B1 (fr) * | 2007-11-15 | 2009-11-20 | Sanofi Aventis | Compositions pharmaceutiques a base de derives d'azetidine |
CN101926757B (zh) | 2010-09-01 | 2013-01-02 | 北京大学 | 一种难溶性药物的液体组合物及其制备方法 |
EP2637655B1 (en) * | 2010-11-08 | 2019-01-09 | Cadila Pharmaceuticals Ltd. | Pharmaceutical composition of taxoids |
EP3086777A1 (en) * | 2013-12-23 | 2016-11-02 | Johnson & Johnson Consumer Inc. | Racecadotril compositions |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0825849A1 (en) * | 1995-05-19 | 1998-03-04 | Abbott Laboratories | Self-emulsifying formulations of lipophilic drugs |
EP1015046A2 (en) * | 1998-07-14 | 2000-07-05 | Em Industries, Inc. | Microdisperse drug delivery systems |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6355631B1 (en) * | 2000-03-03 | 2002-03-12 | Aventis Pharma S.A. | Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation |
FR2814678B1 (fr) * | 2000-10-04 | 2002-12-20 | Aventis Pharma Sa | Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite |
FR2829027A1 (fr) * | 2001-08-29 | 2003-03-07 | Aventis Pharma Sa | Association avec un antagoniste du recepteur cb1, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de parkinson |
FR2833842B1 (fr) * | 2001-12-21 | 2004-02-13 | Aventis Pharma Sa | Compositions pharmaceutiques a base de derives d'azetidine |
EP1498123A1 (en) * | 2003-07-18 | 2005-01-19 | Aventis Pharma S.A. | Emulsifying systems containing azetidine derivatives |
-
2003
- 2003-07-18 EP EP03291796A patent/EP1498122A1/en not_active Withdrawn
-
2004
- 2004-07-01 PE PE2004000634A patent/PE20050287A1/es not_active Application Discontinuation
- 2004-07-08 WO PCT/EP2004/008553 patent/WO2005013973A1/en active Application Filing
- 2004-07-08 CA CA002532669A patent/CA2532669A1/en not_active Abandoned
- 2004-07-08 BR BRPI0412737-4A patent/BRPI0412737A/pt not_active IP Right Cessation
- 2004-07-08 RU RU2006105011/15A patent/RU2343915C2/ru not_active IP Right Cessation
- 2004-07-08 SG SG200804303-6A patent/SG144141A1/en unknown
- 2004-07-08 KR KR1020067001148A patent/KR20060040691A/ko not_active Application Discontinuation
- 2004-07-08 MX MXPA06000483A patent/MXPA06000483A/es not_active Application Discontinuation
- 2004-07-08 EP EP04763639A patent/EP1648442A1/en not_active Withdrawn
- 2004-07-08 JP JP2006519901A patent/JP2009513560A/ja active Pending
- 2004-07-08 RS YUP-2006/0016A patent/RS20060016A/sr unknown
- 2004-07-08 CN CNA2004800206441A patent/CN1822831A/zh active Pending
- 2004-07-08 OA OA1200600018A patent/OA13191A/en unknown
- 2004-07-08 AU AU2004262498A patent/AU2004262498B2/en not_active Ceased
- 2004-07-13 US US10/889,713 patent/US20050026898A1/en not_active Abandoned
- 2004-07-14 PA PA20048606701A patent/PA8606701A1/es unknown
- 2004-07-15 AR ARP040102495A patent/AR045997A1/es not_active Application Discontinuation
- 2004-07-16 GT GT200400135A patent/GT200400135A/es unknown
- 2004-07-16 TW TW093121229A patent/TW200522945A/zh unknown
- 2004-07-16 UY UY28421A patent/UY28421A1/es unknown
- 2004-07-16 MY MYPI20042869A patent/MY142077A/en unknown
- 2004-08-07 UA UAA200601708A patent/UA80633C2/uk unknown
-
2006
- 2006-01-06 CR CR8179A patent/CR8179A/es not_active Application Discontinuation
- 2006-01-12 IL IL173111A patent/IL173111A0/en unknown
- 2006-01-16 MA MA28726A patent/MA27922A1/fr unknown
- 2006-01-17 HR HR20060022A patent/HRP20060022A2/hr not_active Application Discontinuation
- 2006-01-17 ZA ZA200600490A patent/ZA200600490B/en unknown
- 2006-01-17 TN TNP2006000013A patent/TNSN06013A1/en unknown
- 2006-01-17 EC EC2006006292A patent/ECSP066292A/es unknown
- 2006-01-31 NO NO20060509A patent/NO20060509L/no not_active Application Discontinuation
-
2008
- 2008-07-28 US US12/180,691 patent/US20080293686A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1076605A1 (en) | Formulations | |
TNSN06012A1 (en) | Emulsifying systems containing azetidine derivatives | |
TW200621737A (en) | 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof | |
CY1111470T1 (el) | Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α | |
NZ527867A (en) | Oral pharmaceutical composition of cefpodoxime proxetil | |
HRP20041202A2 (en) | Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof | |
MXPA05008960A (es) | Oxazolidinonas de indolona antibacteriales, intermedios para su preparacion y composiciones farmaceuticas que las contienen. | |
TNSN06013A1 (en) | Semi-solid systems containing azetidine derivatives | |
MXPA06000636A (es) | Formulaciones semi-solidas para la administracion oral de taxoides. | |
MY139106A (en) | Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids | |
TW200503785A (en) | Dosage form containing (S)-pantoprazole as active ingredient | |
UA86393C2 (ru) | Производные фениламино-1н-имидазола и фармацевтическая композиция, которая их содержит |